iSpecimen Inc. - Kewajiban jangka dawa perusahaan ISPC

iSpecimen Inc. business relies on strict temperature control and efficiency in the delivery of biological samples. The company is developing a digital subscription ecosystem to connect clinics with researchers, aiming for leadership in the medIT segment. The network effect and a web of verified partners create a sustainable competitive advantage, and the indicator stands at 0.00. The price visualization on GURU.Markets clearly confirms these market positions.

This metric aggregates total long-term liabilities with maturities exceeding twelve months, reflecting the debt load and capital financing strategy. For iSpecimen Inc., which is developing a digital biospecimen marketplace within the ESG framework, the volume of the corporation's long-term loans and borrowings demonstrates a balance between investments in the environmental optimization of logistics and the company's ability to service its debt.